CN116648232A - 洗涤组合物 - Google Patents
洗涤组合物 Download PDFInfo
- Publication number
- CN116648232A CN116648232A CN202180076391.3A CN202180076391A CN116648232A CN 116648232 A CN116648232 A CN 116648232A CN 202180076391 A CN202180076391 A CN 202180076391A CN 116648232 A CN116648232 A CN 116648232A
- Authority
- CN
- China
- Prior art keywords
- composition
- polyglycerol
- betaine
- surfactant
- polyglycerin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 204
- 238000004140 cleaning Methods 0.000 title description 54
- -1 or both Substances 0.000 claims abstract description 54
- 229920006317 cationic polymer Polymers 0.000 claims abstract description 39
- 239000004094 surface-active agent Substances 0.000 claims abstract description 32
- 239000002736 nonionic surfactant Substances 0.000 claims abstract description 27
- 239000002888 zwitterionic surfactant Substances 0.000 claims abstract description 27
- 239000003945 anionic surfactant Substances 0.000 claims abstract description 24
- 239000002280 amphoteric surfactant Substances 0.000 claims abstract description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 21
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 claims description 36
- 229960003237 betaine Drugs 0.000 claims description 22
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 21
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical class NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims description 20
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 15
- MRUAUOIMASANKQ-UHFFFAOYSA-N cocamidopropyl betaine Chemical compound CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC([O-])=O MRUAUOIMASANKQ-UHFFFAOYSA-N 0.000 claims description 13
- 229940105132 myristate Drugs 0.000 claims description 10
- 229940049964 oleate Drugs 0.000 claims description 10
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 claims description 10
- 229920005862 polyol Polymers 0.000 claims description 10
- 150000003077 polyols Chemical class 0.000 claims description 10
- 229910052700 potassium Inorganic materials 0.000 claims description 10
- 239000011591 potassium Substances 0.000 claims description 10
- TUNFSRHWOTWDNC-UHFFFAOYSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 claims description 10
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 9
- GHVNFZFCNZKVNT-UHFFFAOYSA-M decanoate Chemical compound CCCCCCCCCC([O-])=O GHVNFZFCNZKVNT-UHFFFAOYSA-M 0.000 claims description 9
- POULHZVOKOAJMA-UHFFFAOYSA-M dodecanoate Chemical compound CCCCCCCCCCCC([O-])=O POULHZVOKOAJMA-UHFFFAOYSA-M 0.000 claims description 9
- IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 claims description 9
- 229940070765 laurate Drugs 0.000 claims description 9
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims description 9
- WWZKQHOCKIZLMA-UHFFFAOYSA-M octanoate Chemical compound CCCCCCCC([O-])=O WWZKQHOCKIZLMA-UHFFFAOYSA-M 0.000 claims description 9
- 229910052708 sodium Inorganic materials 0.000 claims description 9
- 239000011734 sodium Substances 0.000 claims description 9
- 229940071160 cocoate Drugs 0.000 claims description 8
- 229940073507 cocamidopropyl betaine Drugs 0.000 claims description 7
- 229920000223 polyglycerol Polymers 0.000 claims description 7
- RKWGIWYCVPQPMF-UHFFFAOYSA-N Chloropropamide Chemical compound CCCNC(=O)NS(=O)(=O)C1=CC=C(Cl)C=C1 RKWGIWYCVPQPMF-UHFFFAOYSA-N 0.000 claims description 6
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 6
- 239000004354 Hydroxyethyl cellulose Substances 0.000 claims description 5
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 claims description 5
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 claims description 5
- 229940094506 lauryl betaine Drugs 0.000 claims description 5
- DVEKCXOJTLDBFE-UHFFFAOYSA-N n-dodecyl-n,n-dimethylglycinate Chemical compound CCCCCCCCCCCC[N+](C)(C)CC([O-])=O DVEKCXOJTLDBFE-UHFFFAOYSA-N 0.000 claims description 5
- 125000002252 acyl group Chemical group 0.000 claims description 4
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 4
- 150000002148 esters Chemical class 0.000 claims description 4
- PSBDWGZCVUAZQS-UHFFFAOYSA-N (dimethylsulfonio)acetate Chemical compound C[S+](C)CC([O-])=O PSBDWGZCVUAZQS-UHFFFAOYSA-N 0.000 claims description 3
- HVYJSOSGTDINLW-UHFFFAOYSA-N 2-[dimethyl(octadecyl)azaniumyl]acetate Chemical compound CCCCCCCCCCCCCCCCCC[N+](C)(C)CC([O-])=O HVYJSOSGTDINLW-UHFFFAOYSA-N 0.000 claims description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 3
- RXMUKMSXIXSYOA-UHFFFAOYSA-N carboxymethyl-[3-(dodecanoylamino)propyl]-dimethylazanium;hydroxide Chemical compound [OH-].CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC(O)=O RXMUKMSXIXSYOA-UHFFFAOYSA-N 0.000 claims description 3
- YIOHILISQLOJJV-AFEZEDKISA-N carboxymethyl-dimethyl-[(z)-octadec-9-enyl]azanium;hydroxide Chemical compound [OH-].CCCCCCCC\C=C/CCCCCCCC[N+](C)(C)CC(O)=O YIOHILISQLOJJV-AFEZEDKISA-N 0.000 claims description 3
- 108700019599 monomethylolglycine Proteins 0.000 claims description 3
- 125000002801 octanoyl group Chemical group C(CCCCCCC)(=O)* 0.000 claims description 3
- 229940101011 sodium hydroxymethylglycinate Drugs 0.000 claims description 3
- CITBNDNUEPMTFC-UHFFFAOYSA-M sodium;2-(hydroxymethylamino)acetate Chemical compound [Na+].OCNCC([O-])=O CITBNDNUEPMTFC-UHFFFAOYSA-M 0.000 claims description 3
- 229940117986 sulfobetaine Drugs 0.000 claims description 3
- 235000003222 Helianthus annuus Nutrition 0.000 claims description 2
- OGUKJRCPWCNIQL-QFHJOOASSA-N n-methyl-n-[(2s,3r,4r,5r)-2,3,4,5,6-pentahydroxyhexyl]dodecanamide Chemical group CCCCCCCCCCCC(=O)N(C)C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO OGUKJRCPWCNIQL-QFHJOOASSA-N 0.000 claims description 2
- GBMPATKVZSIKPO-UYWIDEMCSA-N n-methyl-n-[(2s,3r,4r,5r)-2,3,4,5,6-pentahydroxyhexyl]tetradecanamide Chemical compound CCCCCCCCCCCCCC(=O)N(C)C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO GBMPATKVZSIKPO-UYWIDEMCSA-N 0.000 claims description 2
- GOJYXPWOUJYXJC-UHFFFAOYSA-M sodium;2-[1-(2-hydroxyethyl)-2-undecyl-4,5-dihydroimidazol-1-ium-1-yl]acetate;hydroxide Chemical compound [OH-].[Na+].CCCCCCCCCCCC1=NCC[N+]1(CCO)CC([O-])=O GOJYXPWOUJYXJC-UHFFFAOYSA-M 0.000 claims 3
- VFKZECOCJCGZQK-UHFFFAOYSA-M 3-hydroxypropyl(trimethyl)azanium;chloride Chemical compound [Cl-].C[N+](C)(C)CCCO VFKZECOCJCGZQK-UHFFFAOYSA-M 0.000 claims 2
- RFRMMZAKBNXNHE-UHFFFAOYSA-N 6-[4,6-dihydroxy-5-(2-hydroxyethoxy)-2-(hydroxymethyl)oxan-3-yl]oxy-2-(hydroxymethyl)-5-(2-hydroxypropoxy)oxane-3,4-diol Chemical compound CC(O)COC1C(O)C(O)C(CO)OC1OC1C(O)C(OCCO)C(O)OC1CO RFRMMZAKBNXNHE-UHFFFAOYSA-N 0.000 claims 2
- 241000208818 Helianthus Species 0.000 claims 1
- 229940096362 cocoamphoacetate Drugs 0.000 claims 1
- 125000003074 decanoyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C(*)=O 0.000 claims 1
- 239000000230 xanthan gum Substances 0.000 claims 1
- 229920001285 xanthan gum Polymers 0.000 claims 1
- 235000010493 xanthan gum Nutrition 0.000 claims 1
- 229940082509 xanthan gum Drugs 0.000 claims 1
- 210000001508 eye Anatomy 0.000 abstract description 16
- 239000003795 chemical substances by application Substances 0.000 description 21
- 229920000642 polymer Polymers 0.000 description 19
- 238000005406 washing Methods 0.000 description 19
- 239000000047 product Substances 0.000 description 13
- 229940104261 taurate Drugs 0.000 description 13
- 239000003755 preservative agent Substances 0.000 description 12
- 125000000217 alkyl group Chemical group 0.000 description 9
- 239000003093 cationic surfactant Substances 0.000 description 9
- 125000004432 carbon atom Chemical group C* 0.000 description 8
- 238000011156 evaluation Methods 0.000 description 7
- 239000003921 oil Substances 0.000 description 7
- 235000019198 oils Nutrition 0.000 description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- 230000002335 preservative effect Effects 0.000 description 6
- 239000002253 acid Substances 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- VGMJYYDKPUPTID-UHFFFAOYSA-N 4-ethylbenzene-1,3-diol Chemical compound CCC1=CC=C(O)C=C1O VGMJYYDKPUPTID-UHFFFAOYSA-N 0.000 description 4
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 4
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 4
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 4
- 125000002091 cationic group Chemical group 0.000 description 4
- 235000014113 dietary fatty acids Nutrition 0.000 description 4
- 239000000194 fatty acid Substances 0.000 description 4
- 229930195729 fatty acid Natural products 0.000 description 4
- 229960005150 glycerol Drugs 0.000 description 4
- 235000011187 glycerol Nutrition 0.000 description 4
- 229910052757 nitrogen Inorganic materials 0.000 description 4
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 4
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 4
- 239000002453 shampoo Substances 0.000 description 4
- 230000000007 visual effect Effects 0.000 description 4
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 3
- 206010015946 Eye irritation Diseases 0.000 description 3
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 3
- 241000282372 Panthera onca Species 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 3
- 150000001720 carbohydrates Chemical group 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 210000000795 conjunctiva Anatomy 0.000 description 3
- 239000002537 cosmetic Substances 0.000 description 3
- 239000003974 emollient agent Substances 0.000 description 3
- 231100000013 eye irritation Toxicity 0.000 description 3
- 239000003205 fragrance Substances 0.000 description 3
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 3
- 230000007794 irritation Effects 0.000 description 3
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical class OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 125000002811 oleoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])/C([H])=C([H])\C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- 239000002304 perfume Substances 0.000 description 3
- 239000002243 precursor Substances 0.000 description 3
- 229930002330 retinoic acid Natural products 0.000 description 3
- 230000000475 sunscreen effect Effects 0.000 description 3
- 239000000516 sunscreening agent Substances 0.000 description 3
- 229960001727 tretinoin Drugs 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- ULQISTXYYBZJSJ-UHFFFAOYSA-N 12-hydroxyoctadecanoic acid Chemical compound CCCCCCC(O)CCCCCCCCCCC(O)=O ULQISTXYYBZJSJ-UHFFFAOYSA-N 0.000 description 2
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 description 2
- TXFPEBPIARQUIG-UHFFFAOYSA-N 4'-hydroxyacetophenone Chemical compound CC(=O)C1=CC=C(O)C=C1 TXFPEBPIARQUIG-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- MMOXZBCLCQITDF-UHFFFAOYSA-N N,N-diethyl-m-toluamide Chemical compound CCN(CC)C(=O)C1=CC=CC(C)=C1 MMOXZBCLCQITDF-UHFFFAOYSA-N 0.000 description 2
- IZWSFJTYBVKZNK-UHFFFAOYSA-O N-dodecyl-N,N-dimethyl-3-ammonio-1-propanesulfonic acid Chemical compound CCCCCCCCCCCC[N+](C)(C)CCCS(O)(=O)=O IZWSFJTYBVKZNK-UHFFFAOYSA-O 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N Propionic acid Substances CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 2
- 239000004288 Sodium dehydroacetate Substances 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 150000001335 aliphatic alkanes Chemical class 0.000 description 2
- 125000003342 alkenyl group Chemical group 0.000 description 2
- 150000008051 alkyl sulfates Chemical class 0.000 description 2
- 125000002947 alkylene group Chemical group 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 235000019270 ammonium chloride Nutrition 0.000 description 2
- 210000005252 bulbus oculi Anatomy 0.000 description 2
- 229920003086 cellulose ether Polymers 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 210000000744 eyelid Anatomy 0.000 description 2
- 230000001815 facial effect Effects 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- CBKLICUQYUTWQL-XWGBWKJCSA-N methyl (3s,4r)-3-methyl-1-(2-phenylethyl)-4-(n-propanoylanilino)piperidine-4-carboxylate;oxalic acid Chemical compound OC(=O)C(O)=O.CCC(=O)N([C@]1([C@H](CN(CCC=2C=CC=CC=2)CC1)C)C(=O)OC)C1=CC=CC=C1 CBKLICUQYUTWQL-XWGBWKJCSA-N 0.000 description 2
- 229940071088 methyl cocoyl taurate Drugs 0.000 description 2
- 229960003966 nicotinamide Drugs 0.000 description 2
- 235000005152 nicotinamide Nutrition 0.000 description 2
- 239000011570 nicotinamide Substances 0.000 description 2
- 231100000344 non-irritating Toxicity 0.000 description 2
- 150000002924 oxiranes Chemical class 0.000 description 2
- 239000003002 pH adjusting agent Substances 0.000 description 2
- 229940023569 palmate Drugs 0.000 description 2
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- CNVZJPUDSLNTQU-SEYXRHQNSA-N petroselinic acid Chemical compound CCCCCCCCCCC\C=C/CCCCC(O)=O CNVZJPUDSLNTQU-SEYXRHQNSA-N 0.000 description 2
- 235000021317 phosphate Nutrition 0.000 description 2
- 229950001046 piroctone Drugs 0.000 description 2
- 229920000371 poly(diallyldimethylammonium chloride) polymer Polymers 0.000 description 2
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 2
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 description 2
- 239000011769 retinyl palmitate Substances 0.000 description 2
- 229940108325 retinyl palmitate Drugs 0.000 description 2
- 235000019172 retinyl palmitate Nutrition 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- NDVLTYZPCACLMA-UHFFFAOYSA-N silver oxide Chemical compound [O-2].[Ag+].[Ag+] NDVLTYZPCACLMA-UHFFFAOYSA-N 0.000 description 2
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 2
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 2
- 239000004299 sodium benzoate Substances 0.000 description 2
- 235000010234 sodium benzoate Nutrition 0.000 description 2
- 229940079776 sodium cocoyl isethionate Drugs 0.000 description 2
- 235000019259 sodium dehydroacetate Nutrition 0.000 description 2
- 229940079839 sodium dehydroacetate Drugs 0.000 description 2
- 229940048109 sodium methyl cocoyl taurate Drugs 0.000 description 2
- DSOWAKKSGYUMTF-GZOLSCHFSA-M sodium;(1e)-1-(6-methyl-2,4-dioxopyran-3-ylidene)ethanolate Chemical compound [Na+].C\C([O-])=C1/C(=O)OC(C)=CC1=O DSOWAKKSGYUMTF-GZOLSCHFSA-M 0.000 description 2
- IKGKWKGYFJBGQJ-UHFFFAOYSA-M sodium;2-(dodecanoylamino)acetate Chemical group [Na+].CCCCCCCCCCCC(=O)NCC([O-])=O IKGKWKGYFJBGQJ-UHFFFAOYSA-M 0.000 description 2
- CAVXVRQDZKMZDB-UHFFFAOYSA-M sodium;2-[dodecanoyl(methyl)amino]ethanesulfonate Chemical compound [Na+].CCCCCCCCCCCC(=O)N(C)CCS([O-])(=O)=O CAVXVRQDZKMZDB-UHFFFAOYSA-M 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- AGGIJOLULBJGTQ-UHFFFAOYSA-N sulfoacetic acid Chemical class OC(=O)CS(O)(=O)=O AGGIJOLULBJGTQ-UHFFFAOYSA-N 0.000 description 2
- 239000003760 tallow Substances 0.000 description 2
- 229960003080 taurine Drugs 0.000 description 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
- 230000000699 topical effect Effects 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- 235000019155 vitamin A Nutrition 0.000 description 2
- 239000011719 vitamin A Substances 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 235000019166 vitamin D Nutrition 0.000 description 2
- 239000011710 vitamin D Substances 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 235000019168 vitamin K Nutrition 0.000 description 2
- 239000011712 vitamin K Substances 0.000 description 2
- WWUZIQQURGPMPG-UHFFFAOYSA-N (-)-D-erythro-Sphingosine Natural products CCCCCCCCCCCCCC=CC(O)C(N)CO WWUZIQQURGPMPG-UHFFFAOYSA-N 0.000 description 1
- CRDAMVZIKSXKFV-FBXUGWQNSA-N (2-cis,6-cis)-farnesol Chemical compound CC(C)=CCC\C(C)=C/CC\C(C)=C/CO CRDAMVZIKSXKFV-FBXUGWQNSA-N 0.000 description 1
- 239000000260 (2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol Substances 0.000 description 1
- WCGUUGGRBIKTOS-GPOJBZKASA-N (3beta)-3-hydroxyurs-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C WCGUUGGRBIKTOS-GPOJBZKASA-N 0.000 description 1
- RBCOYOYDYNXAFA-UHFFFAOYSA-L (5-hydroxy-4,6-dimethylpyridin-3-yl)methyl phosphate Chemical compound CC1=NC=C(COP([O-])([O-])=O)C(C)=C1O RBCOYOYDYNXAFA-UHFFFAOYSA-L 0.000 description 1
- OJISWRZIEWCUBN-QIRCYJPOSA-N (E,E,E)-geranylgeraniol Chemical compound CC(C)=CCC\C(C)=C\CC\C(C)=C\CC\C(C)=C\CO OJISWRZIEWCUBN-QIRCYJPOSA-N 0.000 description 1
- 229940031723 1,2-octanediol Drugs 0.000 description 1
- ZXSQEZNORDWBGZ-UHFFFAOYSA-N 1,3-dihydropyrrolo[2,3-b]pyridin-2-one Chemical compound C1=CN=C2NC(=O)CC2=C1 ZXSQEZNORDWBGZ-UHFFFAOYSA-N 0.000 description 1
- OWEGWHBOCFMBLP-UHFFFAOYSA-N 1-(4-chlorophenoxy)-1-(1H-imidazol-1-yl)-3,3-dimethylbutan-2-one Chemical compound C1=CN=CN1C(C(=O)C(C)(C)C)OC1=CC=C(Cl)C=C1 OWEGWHBOCFMBLP-UHFFFAOYSA-N 0.000 description 1
- QJNQZLCZCZEFAW-UHFFFAOYSA-N 1-methoxy-1-oxododecane-2-sulfonic acid;sodium Chemical compound [Na].CCCCCCCCCCC(S(O)(=O)=O)C(=O)OC QJNQZLCZCZEFAW-UHFFFAOYSA-N 0.000 description 1
- WJDJWDHXZBNQNE-UHFFFAOYSA-M 1-octadecylpyridin-1-ium;chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 WJDJWDHXZBNQNE-UHFFFAOYSA-M 0.000 description 1
- 229940114072 12-hydroxystearic acid Drugs 0.000 description 1
- OXEDXHIBHVMDST-UHFFFAOYSA-N 12Z-octadecenoic acid Natural products CCCCCC=CCCCCCCCCCCC(O)=O OXEDXHIBHVMDST-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- GOHZKUSWWGUUNR-UHFFFAOYSA-N 2-(4,5-dihydroimidazol-1-yl)ethanol Chemical compound OCCN1CCN=C1 GOHZKUSWWGUUNR-UHFFFAOYSA-N 0.000 description 1
- AMRBZKOCOOPYNY-QXMHVHEDSA-N 2-[dimethyl-[(z)-octadec-9-enyl]azaniumyl]acetate Chemical compound CCCCCCCC\C=C/CCCCCCCC[N+](C)(C)CC([O-])=O AMRBZKOCOOPYNY-QXMHVHEDSA-N 0.000 description 1
- TYIOVYZMKITKRO-UHFFFAOYSA-N 2-[hexadecyl(dimethyl)azaniumyl]acetate Chemical compound CCCCCCCCCCCCCCCC[N+](C)(C)CC([O-])=O TYIOVYZMKITKRO-UHFFFAOYSA-N 0.000 description 1
- AHRBWLCVMUBFNL-UHFFFAOYSA-N 2-hydroxypropanoate;octadecylazanium Chemical compound CC(O)C([O-])=O.CCCCCCCCCCCCCCCCCC[NH3+] AHRBWLCVMUBFNL-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- ANZUDYZHSVGBRF-UHFFFAOYSA-N 3-ethylnonane-1,2,3-triol Chemical compound CCCCCCC(O)(CC)C(O)CO ANZUDYZHSVGBRF-UHFFFAOYSA-N 0.000 description 1
- 229940099451 3-iodo-2-propynylbutylcarbamate Drugs 0.000 description 1
- WYVVKGNFXHOCQV-UHFFFAOYSA-N 3-iodoprop-2-yn-1-yl butylcarbamate Chemical compound CCCCNC(=O)OCC#CI WYVVKGNFXHOCQV-UHFFFAOYSA-N 0.000 description 1
- ANTLBIMVNRRJNP-UHFFFAOYSA-N 4-(2-phenylethyl)benzene-1,3-diol Chemical compound OC1=CC(O)=CC=C1CCC1=CC=CC=C1 ANTLBIMVNRRJNP-UHFFFAOYSA-N 0.000 description 1
- 239000004101 4-Hexylresorcinol Substances 0.000 description 1
- OSDLLIBGSJNGJE-UHFFFAOYSA-N 4-chloro-3,5-dimethylphenol Chemical compound CC1=CC(O)=CC(C)=C1Cl OSDLLIBGSJNGJE-UHFFFAOYSA-N 0.000 description 1
- NZLWYNBRWDATJO-UHFFFAOYSA-N 4-cyclohexyl-5-methylbenzene-1,3-diol Chemical compound CC1=CC(O)=CC(O)=C1C1CCCCC1 NZLWYNBRWDATJO-UHFFFAOYSA-N 0.000 description 1
- LSEHCENPUMUIKC-UHFFFAOYSA-N 4-cyclohexylbenzene-1,3-diol Chemical compound OC1=CC(O)=CC=C1C1CCCCC1 LSEHCENPUMUIKC-UHFFFAOYSA-N 0.000 description 1
- IXMNGROEFGBSGO-UHFFFAOYSA-N 4-cyclopentylbenzene-1,3-diol Chemical compound OC1=CC(O)=CC=C1C1CCCC1 IXMNGROEFGBSGO-UHFFFAOYSA-N 0.000 description 1
- WFJIVOKAWHGMBH-UHFFFAOYSA-N 4-hexylbenzene-1,3-diol Chemical compound CCCCCCC1=CC=C(O)C=C1O WFJIVOKAWHGMBH-UHFFFAOYSA-N 0.000 description 1
- 235000019360 4-hexylresorcinol Nutrition 0.000 description 1
- LNFVQIGQENWZQN-UHFFFAOYSA-N 4-propan-2-ylbenzene-1,3-diol Chemical compound CC(C)C1=CC=C(O)C=C1O LNFVQIGQENWZQN-UHFFFAOYSA-N 0.000 description 1
- FBSIDCYWGKQYRW-UHFFFAOYSA-N 5-methyl-4-propan-2-ylbenzene-1,3-diol Chemical compound CC(C)C1=C(C)C=C(O)C=C1O FBSIDCYWGKQYRW-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- JBYXPOFIGCOSSB-GOJKSUSPSA-N 9-cis,11-trans-octadecadienoic acid Chemical compound CCCCCC\C=C\C=C/CCCCCCCC(O)=O JBYXPOFIGCOSSB-GOJKSUSPSA-N 0.000 description 1
- 241000722941 Achillea Species 0.000 description 1
- 244000144927 Aloe barbadensis Species 0.000 description 1
- 235000002961 Aloe barbadensis Nutrition 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- 206010006784 Burning sensation Diseases 0.000 description 1
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 1
- 235000007866 Chamaemelum nobile Nutrition 0.000 description 1
- 240000008067 Cucumis sativus Species 0.000 description 1
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 1
- 244000007835 Cyamopsis tetragonoloba Species 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- FMRHJJZUHUTGKE-UHFFFAOYSA-N Ethylhexyl salicylate Chemical compound CCCCC(CC)COC(=O)C1=CC=CC=C1O FMRHJJZUHUTGKE-UHFFFAOYSA-N 0.000 description 1
- 240000004670 Glycyrrhiza echinata Species 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- 244000020551 Helianthus annuus Species 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 206010023644 Lacrimation increased Diseases 0.000 description 1
- 102220549062 Low molecular weight phosphotyrosine protein phosphatase_C13S_mutation Human genes 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 244000042664 Matricaria chamomilla Species 0.000 description 1
- 235000007232 Matricaria chamomilla Nutrition 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 241000282320 Panthera leo Species 0.000 description 1
- CNVZJPUDSLNTQU-UHFFFAOYSA-N Petroselaidic acid Natural products CCCCCCCCCCCC=CCCCCC(O)=O CNVZJPUDSLNTQU-UHFFFAOYSA-N 0.000 description 1
- ABLZXFCXXLZCGV-UHFFFAOYSA-N Phosphorous acid Chemical class OP(O)=O ABLZXFCXXLZCGV-UHFFFAOYSA-N 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 102220470542 Proteasome subunit beta type-3_C14S_mutation Human genes 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- VBIIFPGSPJYLRR-UHFFFAOYSA-M Stearyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)C VBIIFPGSPJYLRR-UHFFFAOYSA-M 0.000 description 1
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical compound OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- 235000007303 Thymus vulgaris Nutrition 0.000 description 1
- 240000002657 Thymus vulgaris Species 0.000 description 1
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- OEWBEINAQKIQLZ-CMRBMDBWSA-N [(2s)-2-[(2r)-3,4-bis(2-hexyldecanoyloxy)-5-oxo-2h-furan-2-yl]-2-(2-hexyldecanoyloxy)ethyl] 2-hexyldecanoate Chemical compound CCCCCCCCC(CCCCCC)C(=O)OC[C@H](OC(=O)C(CCCCCC)CCCCCCCC)[C@H]1OC(=O)C(OC(=O)C(CCCCCC)CCCCCCCC)=C1OC(=O)C(CCCCCC)CCCCCCCC OEWBEINAQKIQLZ-CMRBMDBWSA-N 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Natural products OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- WUOACPNHFRMFPN-UHFFFAOYSA-N alpha-terpineol Chemical compound CC1=CCC(C(C)(C)O)CC1 WUOACPNHFRMFPN-UHFFFAOYSA-N 0.000 description 1
- 150000001412 amines Chemical group 0.000 description 1
- 150000003863 ammonium salts Chemical group 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940053195 antiepileptics hydantoin derivative Drugs 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 description 1
- 229960001950 benzethonium chloride Drugs 0.000 description 1
- 235000019445 benzyl alcohol Nutrition 0.000 description 1
- XIWFQDBQMCDYJT-UHFFFAOYSA-M benzyl-dimethyl-tridecylazanium;chloride Chemical compound [Cl-].CCCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1 XIWFQDBQMCDYJT-UHFFFAOYSA-M 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- 210000001217 buttock Anatomy 0.000 description 1
- 125000001589 carboacyl group Chemical group 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000004181 carboxyalkyl group Chemical group 0.000 description 1
- 125000002843 carboxylic acid group Chemical group 0.000 description 1
- MRUAUOIMASANKQ-UHFFFAOYSA-O carboxymethyl-[3-(dodecanoylamino)propyl]-dimethylazanium Chemical compound CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC(O)=O MRUAUOIMASANKQ-UHFFFAOYSA-O 0.000 description 1
- 229960002798 cetrimide Drugs 0.000 description 1
- 229960001927 cetylpyridinium chloride Drugs 0.000 description 1
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 229960005443 chloroxylenol Drugs 0.000 description 1
- SOYKEARSMXGVTM-UHFFFAOYSA-N chlorphenamine Chemical compound C=1C=CC=NC=1C(CCN(C)C)C1=CC=C(Cl)C=C1 SOYKEARSMXGVTM-UHFFFAOYSA-N 0.000 description 1
- 229960003291 chlorphenamine Drugs 0.000 description 1
- 229960003344 climbazole Drugs 0.000 description 1
- 229940080421 coco glucoside Drugs 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000001010 compromised effect Effects 0.000 description 1
- 239000007859 condensation product Substances 0.000 description 1
- 229940108924 conjugated linoleic acid Drugs 0.000 description 1
- 125000000853 cresyl group Chemical group C1(=CC=C(C=C1)C)* 0.000 description 1
- INSRQEMEVAMETL-UHFFFAOYSA-N decane-1,1-diol Chemical compound CCCCCCCCCC(O)O INSRQEMEVAMETL-UHFFFAOYSA-N 0.000 description 1
- SQIFACVGCPWBQZ-UHFFFAOYSA-N delta-terpineol Natural products CC(C)(O)C1CCC(=C)CC1 SQIFACVGCPWBQZ-UHFFFAOYSA-N 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- NAPSCFZYZVSQHF-UHFFFAOYSA-N dimantine Chemical compound CCCCCCCCCCCCCCCCCCN(C)C NAPSCFZYZVSQHF-UHFFFAOYSA-N 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- NTLIJZACUWTZFB-UHFFFAOYSA-N dimethyl-[3-(octadecanoylamino)propyl]azanium;2-hydroxypropanoate Chemical compound CC(O)C(O)=O.CCCCCCCCCCCCCCCCCC(=O)NCCCN(C)C NTLIJZACUWTZFB-UHFFFAOYSA-N 0.000 description 1
- GQOKIYDTHHZSCJ-UHFFFAOYSA-M dimethyl-bis(prop-2-enyl)azanium;chloride Chemical compound [Cl-].C=CC[N+](C)(C)CC=C GQOKIYDTHHZSCJ-UHFFFAOYSA-M 0.000 description 1
- 229940078443 disodium 2-sulfolaurate Drugs 0.000 description 1
- KKGXXVNMUUFEDZ-UHFFFAOYSA-L disodium;2-sulfonatododecanoate Chemical compound [Na+].[Na+].CCCCCCCCCCC(C([O-])=O)S([O-])(=O)=O KKGXXVNMUUFEDZ-UHFFFAOYSA-L 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 239000010642 eucalyptus oil Substances 0.000 description 1
- 229940044949 eucalyptus oil Drugs 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 229940043259 farnesol Drugs 0.000 description 1
- 229930002886 farnesol Natural products 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 210000002683 foot Anatomy 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- XWRJRXQNOHXIOX-UHFFFAOYSA-N geranylgeraniol Natural products CC(C)=CCCC(C)=CCOCC=C(C)CCC=C(C)C XWRJRXQNOHXIOX-UHFFFAOYSA-N 0.000 description 1
- OJISWRZIEWCUBN-UHFFFAOYSA-N geranylnerol Natural products CC(C)=CCCC(C)=CCCC(C)=CCCC(C)=CCO OJISWRZIEWCUBN-UHFFFAOYSA-N 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 229940087559 grape seed Drugs 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 210000004247 hand Anatomy 0.000 description 1
- 125000003104 hexanoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229940051250 hexylene glycol Drugs 0.000 description 1
- 229960003258 hexylresorcinol Drugs 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- WJRBRSLFGCUECM-UHFFFAOYSA-N hydantoin Chemical compound O=C1CNC(=O)N1 WJRBRSLFGCUECM-UHFFFAOYSA-N 0.000 description 1
- 229940091173 hydantoin Drugs 0.000 description 1
- 150000001469 hydantoins Chemical class 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- RNYJXPUAFDFIQJ-UHFFFAOYSA-N hydron;octadecan-1-amine;chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[NH3+] RNYJXPUAFDFIQJ-UHFFFAOYSA-N 0.000 description 1
- 125000001165 hydrophobic group Chemical group 0.000 description 1
- 125000004356 hydroxy functional group Chemical group O* 0.000 description 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 description 1
- ZCTXEAQXZGPWFG-UHFFFAOYSA-N imidurea Chemical compound O=C1NC(=O)N(CO)C1NC(=O)NCNC(=O)NC1C(=O)NC(=O)N1CO ZCTXEAQXZGPWFG-UHFFFAOYSA-N 0.000 description 1
- 230000003100 immobilizing effect Effects 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 230000004317 lacrimation Effects 0.000 description 1
- 229940075468 lauramidopropyl betaine Drugs 0.000 description 1
- 125000000400 lauroyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229940071096 lauroyl isethionate Drugs 0.000 description 1
- 239000000171 lavandula angustifolia l. flower oil Substances 0.000 description 1
- 210000002414 leg Anatomy 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000004973 liquid crystal related substance Substances 0.000 description 1
- 229940078752 magnesium ascorbyl phosphate Drugs 0.000 description 1
- 150000002688 maleic acid derivatives Chemical class 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 229960001855 mannitol Drugs 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- HLJAIBPPEVHZDA-UHFFFAOYSA-N methyl sulfate;pyrrolidin-1-ium Chemical compound C1CC[NH2+]C1.COS([O-])(=O)=O HLJAIBPPEVHZDA-UHFFFAOYSA-N 0.000 description 1
- NQNOMXXYKHWVKR-UHFFFAOYSA-N methylazanium;sulfate Chemical compound NC.NC.OS(O)(=O)=O NQNOMXXYKHWVKR-UHFFFAOYSA-N 0.000 description 1
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 235000019426 modified starch Nutrition 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- LPUQAYUQRXPFSQ-DFWYDOINSA-M monosodium L-glutamate Chemical compound [Na+].[O-]C(=O)[C@@H](N)CCC(O)=O LPUQAYUQRXPFSQ-DFWYDOINSA-M 0.000 description 1
- 125000001419 myristoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- XRSFQLOANYRGRT-UHFFFAOYSA-N n,n-dimethyldocosan-1-amine;hydrochloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCCCCCC[NH+](C)C XRSFQLOANYRGRT-UHFFFAOYSA-N 0.000 description 1
- 210000003739 neck Anatomy 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- AEIJTFQOBWATKX-UHFFFAOYSA-N octane-1,2-diol Chemical compound CCCCCCC(O)CO AEIJTFQOBWATKX-UHFFFAOYSA-N 0.000 description 1
- 229960001679 octinoxate Drugs 0.000 description 1
- 235000019645 odor Nutrition 0.000 description 1
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 description 1
- 235000020660 omega-3 fatty acid Nutrition 0.000 description 1
- 229940012843 omega-3 fatty acid Drugs 0.000 description 1
- 239000006014 omega-3 oil Substances 0.000 description 1
- 235000020665 omega-6 fatty acid Nutrition 0.000 description 1
- 229940033080 omega-6 fatty acid Drugs 0.000 description 1
- 239000003605 opacifier Substances 0.000 description 1
- MPQXHAGKBWFSNV-UHFFFAOYSA-N oxidophosphanium Chemical group [PH3]=O MPQXHAGKBWFSNV-UHFFFAOYSA-N 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- OIQJEQLSYJSNDS-UHFFFAOYSA-N piroctone Chemical compound CC(C)(C)CC(C)CC1=CC(C)=CC(=O)N1O OIQJEQLSYJSNDS-UHFFFAOYSA-N 0.000 description 1
- BTSZTGGZJQFALU-UHFFFAOYSA-N piroctone olamine Chemical compound NCCO.CC(C)(C)CC(C)CC1=CC(C)=CC(=O)N1O BTSZTGGZJQFALU-UHFFFAOYSA-N 0.000 description 1
- 239000013502 plastic waste Substances 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 229940068977 polysorbate 20 Drugs 0.000 description 1
- 229960003975 potassium Drugs 0.000 description 1
- 150000003138 primary alcohols Chemical class 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 1
- ROSDSFDQCJNGOL-UHFFFAOYSA-N protonated dimethyl amine Natural products CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000002207 retinal effect Effects 0.000 description 1
- NCYCYZXNIZJOKI-OVSJKPMPSA-N retinal group Chemical group C\C(=C/C=O)\C=C\C=C(\C=C\C1=C(CCCC1(C)C)C)/C NCYCYZXNIZJOKI-OVSJKPMPSA-N 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 229960000342 retinol acetate Drugs 0.000 description 1
- 125000002523 retinol group Chemical group 0.000 description 1
- 239000011770 retinyl acetate Substances 0.000 description 1
- 235000019173 retinyl acetate Nutrition 0.000 description 1
- 235000020748 rosemary extract Nutrition 0.000 description 1
- 229940092258 rosemary extract Drugs 0.000 description 1
- 239000001233 rosmarinus officinalis l. extract Substances 0.000 description 1
- 235000002020 sage Nutrition 0.000 description 1
- YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 description 1
- 238000011012 sanitization Methods 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 150000003333 secondary alcohols Chemical class 0.000 description 1
- CQLFBEKRDQMJLZ-UHFFFAOYSA-M silver acetate Chemical compound [Ag+].CC([O-])=O CQLFBEKRDQMJLZ-UHFFFAOYSA-M 0.000 description 1
- 229940071536 silver acetate Drugs 0.000 description 1
- LKZMBDSASOBTPN-UHFFFAOYSA-L silver carbonate Substances [Ag].[O-]C([O-])=O LKZMBDSASOBTPN-UHFFFAOYSA-L 0.000 description 1
- 229910001958 silver carbonate Inorganic materials 0.000 description 1
- 229910001961 silver nitrate Inorganic materials 0.000 description 1
- 229910001923 silver oxide Inorganic materials 0.000 description 1
- FJOLTQXXWSRAIX-UHFFFAOYSA-K silver phosphate Chemical compound [Ag+].[Ag+].[Ag+].[O-]P([O-])([O-])=O FJOLTQXXWSRAIX-UHFFFAOYSA-K 0.000 description 1
- 229940019931 silver phosphate Drugs 0.000 description 1
- 229910000161 silver phosphate Inorganic materials 0.000 description 1
- YPNVIBVEFVRZPJ-UHFFFAOYSA-L silver sulfate Chemical compound [Ag+].[Ag+].[O-]S([O-])(=O)=O YPNVIBVEFVRZPJ-UHFFFAOYSA-L 0.000 description 1
- 229910000367 silver sulfate Inorganic materials 0.000 description 1
- CLDWGXZGFUNWKB-UHFFFAOYSA-M silver;benzoate Chemical compound [Ag+].[O-]C(=O)C1=CC=CC=C1 CLDWGXZGFUNWKB-UHFFFAOYSA-M 0.000 description 1
- 230000008591 skin barrier function Effects 0.000 description 1
- 229960003885 sodium benzoate Drugs 0.000 description 1
- 229940079781 sodium cocoyl glutamate Drugs 0.000 description 1
- 229940065859 sodium cocoyl glycinate Drugs 0.000 description 1
- 229940045944 sodium lauroyl glutamate Drugs 0.000 description 1
- 229940048106 sodium lauroyl isethionate Drugs 0.000 description 1
- 229940048107 sodium methyl 2-sulfolaurate Drugs 0.000 description 1
- IWIUXJGIDSGWDN-UQKRIMTDSA-M sodium;(2s)-2-(dodecanoylamino)pentanedioate;hydron Chemical compound [Na+].CCCCCCCCCCCC(=O)N[C@H](C([O-])=O)CCC(O)=O IWIUXJGIDSGWDN-UQKRIMTDSA-M 0.000 description 1
- BCISDMIQYBCHAT-UHFFFAOYSA-M sodium;2-(dodecanoylamino)ethanesulfonate Chemical compound [Na+].CCCCCCCCCCCC(=O)NCCS([O-])(=O)=O BCISDMIQYBCHAT-UHFFFAOYSA-M 0.000 description 1
- HJXBXTZDPSSEST-UHFFFAOYSA-M sodium;2-[methyl(tetradecanoyl)amino]ethanesulfonate Chemical compound [Na+].CCCCCCCCCCCCCC(=O)N(C)CCS([O-])(=O)=O HJXBXTZDPSSEST-UHFFFAOYSA-M 0.000 description 1
- IZWPGJFSBABFGL-GMFCBQQYSA-M sodium;2-[methyl-[(z)-octadec-9-enoyl]amino]ethanesulfonate Chemical compound [Na+].CCCCCCCC\C=C/CCCCCCCC(=O)N(C)CCS([O-])(=O)=O IZWPGJFSBABFGL-GMFCBQQYSA-M 0.000 description 1
- BRMSVEGRHOZCAM-UHFFFAOYSA-M sodium;2-dodecanoyloxyethanesulfonate Chemical compound [Na+].CCCCCCCCCCCC(=O)OCCS([O-])(=O)=O BRMSVEGRHOZCAM-UHFFFAOYSA-M 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- LXMSZDCAJNLERA-ZHYRCANASA-N spironolactone Chemical compound C([C@@H]1[C@]2(C)CC[C@@H]3[C@@]4(C)CCC(=O)C=C4C[C@H]([C@@H]13)SC(=O)C)C[C@@]21CCC(=O)O1 LXMSZDCAJNLERA-ZHYRCANASA-N 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 150000003871 sulfonates Chemical class 0.000 description 1
- 125000000542 sulfonic acid group Chemical group 0.000 description 1
- 150000003462 sulfoxides Chemical class 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 210000001138 tear Anatomy 0.000 description 1
- 229940116411 terpineol Drugs 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- 150000005621 tetraalkylammonium salts Chemical class 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- 239000001585 thymus vulgaris Substances 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- CRDAMVZIKSXKFV-UHFFFAOYSA-N trans-Farnesol Natural products CC(C)=CCCC(C)=CCCC(C)=CCO CRDAMVZIKSXKFV-UHFFFAOYSA-N 0.000 description 1
- AQWHMKSIVLSRNY-UHFFFAOYSA-N trans-Octadec-5-ensaeure Natural products CCCCCCCCCCCCC=CCCCC(O)=O AQWHMKSIVLSRNY-UHFFFAOYSA-N 0.000 description 1
- 229960003500 triclosan Drugs 0.000 description 1
- HTJNEBVCZXHBNJ-XCTPRCOBSA-H trimagnesium;(2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;diphosphate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.OC[C@H](O)[C@H]1OC(=O)C(O)=C1O HTJNEBVCZXHBNJ-XCTPRCOBSA-H 0.000 description 1
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical group CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 1
- 229940096998 ursolic acid Drugs 0.000 description 1
- PLSAJKYPRJGMHO-UHFFFAOYSA-N ursolic acid Natural products CC1CCC2(CCC3(C)C(C=CC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C)C(=O)O PLSAJKYPRJGMHO-UHFFFAOYSA-N 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 238000011179 visual inspection Methods 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 150000003700 vitamin C derivatives Chemical class 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 229940043810 zinc pyrithione Drugs 0.000 description 1
- PICXIOQBANWBIZ-UHFFFAOYSA-N zinc;1-oxidopyridine-2-thione Chemical compound [Zn+2].[O-]N1C=CC=CC1=S.[O-]N1C=CC=CC1=S PICXIOQBANWBIZ-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
- A61K8/442—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof substituted by amido group(s)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/42—Amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
- A61K8/466—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfonic acid derivatives; Salts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/602—Glycosides, e.g. rutin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/731—Cellulose; Quaternized cellulose derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/737—Galactomannans, e.g. guar; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/005—Preparations for sensitive skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/54—Polymers characterized by specific structures/properties
- A61K2800/542—Polymers characterized by specific structures/properties characterized by the charge
- A61K2800/5426—Polymers characterized by specific structures/properties characterized by the charge cationic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/54—Polymers characterized by specific structures/properties
- A61K2800/542—Polymers characterized by specific structures/properties characterized by the charge
- A61K2800/5428—Polymers characterized by specific structures/properties characterized by the charge amphoteric or zwitterionic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/596—Mixtures of surface active compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/75—Anti-irritant
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Cosmetics (AREA)
- Detergent Compositions (AREA)
Abstract
本发明涉及一种不刺激眼睛的洗涤组合物。该组合物包含具有阴离子表面活性剂,及两性或两性离子表面活性剂或者两者,及非离子表面活性剂或阳离子聚合物或其混合物的表面活性剂体系。该组合物是水连续的,具有4.8至7.5的pH值,并且令人惊讶地不刺激眼睛,同时为消费者提供所需的起泡特性。
Description
发明领域
本发明涉及不刺激眼睛的洗涤组合物。更具体地,该组合物是包含表面活性剂体系的洗涤组合物,该表面活性剂体系具有阴离子表面活性剂,及两性或两性离子表面活性剂或两者,及非离子表面活性剂或阳离子聚合物或其混合物。该组合物是水连续的,具有多元醇,pH值为4.8至7.5,并且令人惊讶的是,不刺激眼睛,同时为消费者提供所需的皮肤益处和起泡特性。本发明的组合物对于皮肤屏障受损和/或脆弱的消费者(包括婴儿)而言足够温和。
发明背景
通常,消费者希望洗涤组合物不仅用于清洁和消毒,而且用于将皮肤有益剂如保湿剂、抗菌剂和香料沉积到皮肤上。鉴于目前的世界状况(其处于疫情中),强烈地需要更经常地清洗,尤其是手和脸。有鉴于此,消费者需要使用温和且在洗涤时产生足够的泡沫量的产品。消费者还要求他们使用的洗涤组合物不刺激眼睛,尤其是当洗脸变得越来越重要时。当消费者倾向于年幼的人们,尤其是婴儿时,情况尤其如此。
人们对提供很好地清洁和消毒,提供皮肤有益剂,使用温和,并且提供良好的起泡而不引起眼睛刺激的洗涤组合物越来越感兴趣。因此,本发明涉及一种包含表面活性剂体系的组合物,该表面活性剂体系具有阴离子表面活性剂及两性或两性离子表面活性剂或两者,及非离子表面活性剂或阳离子聚合物或其混合物。该组合物是水连续的,具有4.8至7.5的pH值,并且令人惊讶的是,对眼睛没有刺激性,同时提供消费者所需的起泡特性。
附加信息
已经公开了制备洗涤组合物的工作。在美国专利第4,221,733号中,描述了具有甜菜碱并显示眼睛刺激减少的洗涤组合物。
已经公开了用于制备洗涤组合物的其它工作。在美国专利第6,169,060号中,描述了具有阴离子、非离子和两性表面活性剂的清洁组合物。
还公开了用于制备洗涤组合物的其它工作。在美国专利6,372,934中,描述了不刺激眼睛和皮肤并且适用于个人护理组合物的水溶性化合物。
上述附加信息没有任一个描述如所要求保护的本发明所限定的对眼睛温和的洗涤组合物。
发明概述
在第一方面,本发明涉及一种洗涤组合物,其包含:
a)包含以下的表面活性剂组分:
i)两性和/或两性离子表面活性剂;
ii)非离子表面活性剂、阳离子聚合物或其混合物;和
iii)阴离子表面活性剂,该阴离子表面活性剂包含基于阴离子表面活性剂总重量的25至100重量%的牛磺酸盐;
b)大于5至55重量%的多元醇;和
c)水,
其中两性和/或两性离子表面活性剂以及非离子表面活性剂或阳离子聚合物或其混合物(分别“组分i和ii”)与阴离子表面活性剂(“组分iii”)的重量比为1:4至2:1,且两性和/或两性离子表面活性剂(“组分i”)与非离子表面活性剂或阳离子聚合物或其混合物(“组分ii”)的重量比为1:12至12:1,条件是当阳离子聚合物单独使用或与非离子表面活性剂一起使用时,所使用的阳离子聚合物的总重量相对于洗涤组合物中表面活性剂总重量为表面活性剂总重量的1.3重量%至不超过15重量%,并且洗涤组合物包含20重量%或更少的总表面活性剂和阳离子聚合物。
在第二方面,本发明涉及用本发明第一方面的洗涤组合物进行洗涤的方法。
在第三方面,本发明涉及本发明第一方面的组合物用于洗脸和/或头发而不刺激眼睛的用途。
从下面的描述和实施例中,本发明的所有其他方面将变得更加明显。
本文所用的皮肤意在包括手臂(包括腋下)、面部、足部、颈部、胸部、手、腿、臀部和头皮(包括毛发)上的皮肤。如本文所用,“刺激眼睛”是指刺痛或烧灼感,如由接受洗涤组合物的专门小组成员的眼睛的自我评估确定的。它还包括在眼睛接触包含洗涤组合物5%溶液的水性组合物后30秒至一(1)小时内(由受过训练的专业人员)对专门小组成员眼结膜的可见发红的评估和/或眼睛出现刺激或流泪的评估。这种洗涤组合物适合作为洗发水、护发素、三合一洗涤组合物(洗发水、护发素和沐浴露)、二合一洗涤组合物(洗发水和沐浴露)、卸妆水(make-up wash)、洗面奶、洗手液或个人护理液体沐浴露。优选地,本发明的洗涤组合物是沐浴露或洗面奶,其对于应用于皮肤(包括婴儿皮肤)足够温和,适合局部应用,并且适合擦拭或用水洗掉,优选洗掉。洗涤组合物可以任选地包含药用或治疗剂,但是优选地,该组合物是用于去除污垢和/或通常与气味相关的细菌的美容和非治疗性洗涤的洗涤组合物。在本发明的实施方式中,洗涤组合物是特别适用于婴儿的个人洗涤组合物。本发明的洗涤组合物可任选地包含加入其中的皮肤有益成分,例如维生素(如维生素A、D、E和K,尤其是维生素C和/或烟酰胺)和/或其衍生物、间苯二酚类、视黄酸前体、着色剂、保湿剂、防晒剂、其混合物等。皮肤有益成分(或有益剂)可以是水溶性或油溶性的。如果使用,油溶性皮肤有益剂通常占洗涤组合物的至多1.5重量%,而水溶性皮肤有益剂(在使用时)通常占洗涤组合物的至多10重量%。该洗涤组合物通常具有4.8至7.5的pH,优选5至7.5,最优选5.5至7.5。在本发明的实施方式中,洗涤组合物的pH可以是6.0至7.2,包括其中包含的所有范围。除非另有说明,粘度是用Discovery HR-2流变仪使用具有1000微米间隙的喷砂板测量的中,且对于第一粘度VA使用0.4s-1的第一剪切速率SA,和对于第二粘度VB使用10s-1的第二剪切速率SB,两者均在25℃下和以20秒间隔进行。粘度以厘泊(cps)报告(1000厘泊(cps)=1帕斯卡秒)。本文所用的“稳定”是指洗涤组合物在45℃下储存至少一(1)个月,和优选地在45℃下储存2至4个月后没有变色或相分离。术语“包含”意图包括术语“基本上由…组成”和“由…组成”。为了避免疑问和为了用于说明,包含表面活性剂和水的本发明的组合物意味着包括基本上由其组成的组合物和由其组成的组合物。除了在操作对比实施例中,或者另外明确指出的情况下,本说明书中表示材料的量或比例或者条件和/或材料的物理性质和/或用途的所有数字都应理解为用词“约”修饰。除非另有说明,本文定义的所有范围都意味着包括其中包含的所有范围。
发明详述
适用于本发明的两性表面活性剂(其根据pH可以是两性离子的)包括酰基两性乙酸钠、酰基两性丙酸钠、酰基两性二乙酸二钠和酰基两性二丙酸二钠,其中酰基(即烷酰基)可以包含C7-C18烷基部分。适用的两性表面活性剂的说明性实例包括月桂酰两性乙酸钠、椰油酰两性乙酸钠、月桂酰两性乙酸钾、椰油酰两性乙酸钾或其混合物。月桂酰两性乙酸钠是优选使用的两性表面活性剂。当使用时,两性表面活性剂通常占洗涤组合物重量的0.5-7%,优选1-6%,最优选1-5%,包括其中包含的所有范围。
至于可用于本发明洗涤组合物的两性离子表面活性剂,这类表面活性剂包括至少一个酸基团。这种酸基团可以是羧酸或磺酸基团。它们通常包括季氮,且因此可以是季氨基酸。它们通常应该包括7至18个碳原子的烷基或烯基,并且通常符合总体结构式:
R1—[—C(O)—NH(CH2)q—]r—N+(R2)(R3)-A—B
其中R1是7至18个碳原子的烷基或烯基;R2和R3各自独立地是1-3个碳原子的烷基、羟烷基或羧烷基;q是2至4;r为0至1;A是任选被羟基取代的1-3个碳原子的亚烷基,B是-CO2-或-SO3-。
用于本发明的洗涤组合物并在上述通式范围内的通常所需的两性离子表面活性剂包括下式的简单甜菜碱:
R1—N+(R2)(R3)-CH2CO2 -
和下式的酰胺甜菜碱:
R1—CONH(CH2)t—N+(R2)(R3)-CH2CO2 -
其中t是2或3。
在两个式中,R1、R2和R3如前所定义。特别地,R1可以是衍生自椰子油的C12和C14烷基的混合物,使得至少一半,优选至少四分之三的R1基团具有10至14个碳原子。R2和R3优选是甲基。
进一步的可能性是两性离子表面活性剂为磺化甜菜碱(sulphobetaine)和/或磺基甜菜碱(sultaine)。
适用的两性离子表面活性剂的说明性但非限制性的实例包括甜菜碱,例如月桂基甜菜碱、柠檬酸甜菜碱、椰油二甲基羧甲基甜菜碱、椰油酰胺丙基甜菜碱、椰油烷基二甲基甜菜碱和月桂基酰胺丙基甜菜碱。其他适用的两性离子表面活性剂还包括椰油酰胺丙基磺基甜菜碱,如例如,椰油酰胺基丙基羟基磺基甜菜碱。优选的两性离子表面活性剂包括月桂基甜菜碱、柠檬酸甜菜碱、羟甲基甘氨酸钠、(羧甲基)二甲基-3-[(1-氧代十二烷基)氨基]丙基氢氧化铵、椰油烷基二甲基甜菜碱、(羧甲基)二甲基油烯基氢氧化铵、椰油酰胺丙基甜菜碱、(羧甲基)二甲基油烯基氢氧化铵、椰油酰胺丙基甜菜碱、(羧甲基)二甲基(十八烷基)铵((carboxylatomethyl)dimethyl(octadecyl)ammonium)、椰油酰胺丙基羟基磺基甜菜碱或它们的混合物。这类表面活性剂可从供应商如Stepan Company、Solvay、Evonik等商购获得,且使用上述表面活性剂的混合物也在本发明的范围内。
在本发明的实施方式中,用于本发明的两性离子表面活性剂包括椰油二甲基羧甲基甜菜碱、椰油酰胺基丙基甜菜碱和月桂基酰胺丙基甜菜碱。适用的其它优选的两性离子表面活性剂包括椰油酰胺丙基磺基甜菜碱和椰油酰胺丙基羟基磺基甜菜碱。在最优选的实施方式中,用于本发明的两性离子表面活性剂是椰油酰胺基丙基甜菜碱、椰油酰胺丙基羟基磺基甜菜碱或其混合物。当使用时,两性离子表面活性剂通常占洗涤组合物重量的0.5至-7%,优选1至6%,最优选1至5%,包括其中包含的所有范围。
非离子表面活性剂可用于本发明的洗涤组合物中。可以使用的非离子表面活性剂特别地包括具有疏水基团和反应性氢原子的化合物(例如,脂族醇、酸、酰胺或烷基酚)与环氧烷(尤其是单独的环氧乙烷或与环氧丙烷一起)的反应产物。具体的非离子表面活性剂化合物是烷基(C6-C22)酚、环氧乙烷缩合物、脂肪族(C8-C18)直链或支链伯或仲醇与环氧乙烷的缩合产物以及由环氧乙烷与环氧丙烷和乙二胺的反应产物缩合制备的产物。其他非离子表面活性剂包括长链叔胺氧化物、长链叔膦氧化物、二烷基亚砜等。
可用于本发明洗涤组合物的优选非离子表面活性剂是葡糖酰胺、聚甘油酯或其混合物。在本发明的实施方式中,用于本发明的葡糖酰胺包括月桂酰基甲基葡糖酰胺、肉豆蔻酰基甲基葡糖酰胺、椰油酰基甲基葡糖酰胺、辛酰基/己酰基甲基葡糖酰胺、向日葵酰基(sunfloweroyl)甲基葡糖酰胺,其混合物等。优选的葡糖酰胺由Clariant以名称出售。
在本发明的又一个实施方式中,所用的聚甘油酯包括聚甘油-8辛酸酯、聚甘油-8癸酸酯、聚甘油-8月桂酸酯、聚甘油-8肉豆蔻酸酯、聚甘油-8棕榈酸酯、聚甘油-8硬脂酸酯、聚甘油-8油酸酯、聚甘油-8椰油酸酯、聚甘油-9辛酸酯、聚甘油-9癸酸酯、聚甘油-9月桂酸酯、聚甘油-9肉豆蔻酸酯、聚甘油-9棕榈酸酯、聚甘油-9硬脂酸酯、聚甘油-9油酸酯、聚甘油-9椰油酸酯、聚甘油-10辛酸酯、聚甘油-10癸酸酯、聚甘油-10月桂酸酯、聚甘油-10肉豆蔻酸酯、聚甘油-10棕榈酸酯、聚甘油-10硬脂酸酯、聚甘油-10油酸酯、聚甘油-10椰油酸酯、聚甘油-11辛酸酯、聚甘油-11癸酸酯、聚甘油-11月桂酸酯、聚甘油-11肉豆蔻酸酯、聚甘油-11棕榈酸酯、聚甘油-11硬脂酸酯、聚甘油-11油酸酯、聚甘油-11椰油酸酯、聚甘油-12辛酸酯、聚甘油-12癸酸酯、聚甘油-12月桂酸酯、聚甘油-12肉豆蔻酸酯、聚甘油-12棕榈酸酯、聚甘油-12硬脂酸酯、聚甘油-12油酸酯、聚甘油-12椰油酸酯或其混合物。
当非离子表面活性剂用于本发明的洗涤组合物时,这种表面活性剂通常占洗涤组合物重量的0.5至7%,优选1至6%,最优选1至5%,包括其中包含的所有范围。
至于适合任选使用的阳离子聚合物,其包括分类为阳离子瓜尔胶衍生物、合成阳离子聚合物和阳离子淀粉衍生物的聚合物。通常需要使用被分类为部分阳离子取代的季铵盐的那些。
这种类型的合适聚合物符合下面给出的结构:
其中,x为0至3,优选0至1;并且y:n的比率在0.01至0.5的范围内(即n:y=100至2)。在本发明中,希望的是排除具有完全季铵化的糖单元(即y=n)的阳离子聚合物。
未季铵化糖单元与季铵化糖单元的比率(n:y)优选在3至30的范围内,更优选在4至25的范围内,最优选在5至20的范围内。
合适的聚合物的重均分子量在100至3,000,000kDa的范围内,优选500至1,000,000kDa,更优选10,000至500,000kDa,并且可以使用聚合物的混合物。在本发明的一个实施方式中,聚合物的重均分子量为150至100,000kDa。在另一个实施方式中,聚合物的重均分子量为200至3,000kDa。在又一个实施方式中,聚合物的重均分子量为250至2,500kDa。
优选使用的阳离子聚合物是指含季氮的多糖,更优选地,含季氮的纤维素醚,例如,美国专利No.3,472,840;3,962,418;4,663,159,美国专利No.5,407,919和WO2005/000903 A1中描述的那些,其公开内容通过引用并入本文。特别优选的阳离子聚合物是含季氮的羟乙基纤维素。阳离子聚合物的合适实例是羟乙基纤维素与三甲基铵取代的环氧化物反应的盐,在工业中由化妆品、盥洗用品和香料协会(CTFA)称为聚季铵盐-10,其可从DowChemical Company的子公司Amerchol Corporation以UCARETMPolymer JR-125、UCAREPolymer JR-400、UCARE Polymer KF、UCARE Polymer JR-30M、UCARE Polymer LR-400、UCARE Polymer LR-30M和UCARE Polymer LK购得。其它优选的阳离子聚合物的实例被CTFA称作聚季铵盐-67。它们可以作为SoftCATTM聚合物从Amerchol Corp.购得,如SoftCAT SL5、SoftCAT SL 30、SoftCAT SL 60、SoftCAT SL 100、SoftCAT SK-L、SoftCAT SK-M、SoftCAT SK-M、SoftCAT SK-MH、SoftCAT SK-H、SoftCAT SX-400X、SoftCAT SX-400H、SoftCAT SX-1300X和SoftCAT SX-1300H。优选的阳离子聚合物的其它实例是在工业中被CTFA称为聚季铵盐-6(即PDADMAC,聚二烯丙基二甲基氯化铵)和聚季铵盐-7(CAS登记号分别为26062-79-3和026590-05-6)的那些,以及被CTFA称为聚季铵盐-44的那些。其它合适的聚合物还包括购自Solvay的Jaguar C13S、Jaguar C14S和Jaguar C17,以及购自Lubrizol的MerquatTM100等。甚至其它类型的阳离子纤维素醚包括羟乙基纤维素与月桂基二甲基铵取代的环氧化物反应的聚合季铵盐,在工业(CTFA)中称为聚季铵盐24。
在本发明的实施方式中,所用的阳离子聚合物是在阳离子聚合物和水的1%溶液中产生的粘度为150至4000cps,优选200至3500cps,最优选300至2500cps的那些。在又一个实施方式中,这种溶液具有275至2100cps的粘度,包括其中包含的所有范围。
关于阳离子聚合物中氮的取代百分比(按重量计)(即阳离子取代),基于阳离子聚合物的总重量,通常氮百分比为0.1至4重量%,优选0.3至3.5重量%,最优选1至2.8重量%。
通常,当使用时,阳离子聚合物将占洗涤组合物中使用的表面活性剂总重量的1.3至不超过15重量%。阳离子聚合物通常占洗涤组合物中使用的表面活性剂总重量的1.5至12重量%,更通常为4至12重量%。在本发明的实施方式中,阳离子聚合物占洗涤组合物中使用的表面活性剂总重量的5至11重量%,优选6至10重量%。
任选地,阳离子表面活性剂可以包含在本发明的洗涤组合物中。可以使用的那些包括杂环铵盐,例如,十六烷基或十八烷基氯化吡啶鎓、烷基酰胺乙基甲基硫酸吡咯烷鎓(pyrrylinodium)、拉匹氯铵或其混合物。
四烷基铵盐是另一类有用的任选阳离子表面活性剂。实例包括十六烷基或十八烷基三甲基氯化铵或溴化铵;氢化棕榈油或牛油三甲基卤化铵;二十二烷基三甲基卤化铵或甲基硫酸铵;癸基异壬基二甲基卤化铵;二牛油基(或二硬脂基)二甲基卤化铵和二十二烷基二甲基氯化铵。
可以使用的再其它类型的阳离子表面活性剂是各种乙氧基化的季胺和酯季铵盐。实例包括PEG-5硬脂基乳酸铵(例如,由Clariant制造的Genamin KSL)、PEG-2椰油基氯化铵、PEG-15氢化牛油基氯化铵、PEG-15硬脂基氯化铵、二棕榈酰基乙基甲基氯化铵、二棕榈酰基羟乙基甲基硫酸盐和硬脂酰胺丙基二甲基乳酸胺。
甚至其它有用但任选的阳离子表面活性剂包括丝、小麦和角蛋白的季铵化水解产物,使用上述阳离子表面活性剂的混合物也在洗涤组合物的范围内。
如果使用,阳离子表面活性剂通常占洗涤组合物中表面活性剂总重量的不超过3重量%。当存在时,阳离子表面活性剂通常占洗涤组合物中使用的表面活性剂总重量的0.01至2.5重量%,更通常为0.1至1.5重量%,包括其中包含的所有范围。
在本发明的实施方式中,当使用时,阳离子表面活性剂占洗涤组合物中使用的阳离子聚合物和阳离子表面活性剂的总重量的0.01至6重量%,优选0.1至3重量%。
至于适用于本发明的阴离子表面活性剂,基于组合物中阴离子表面活性剂的总重量,其包含25至100重量%,优选30至100重量%,最优选50至100重量%的牛磺酸盐表面活性剂。在本发明的再另一个实施方式中,阴离子表面活性剂是包含85至100重量%的牛磺酸盐的表面活性剂。而在另一个实施方式中,牛磺酸盐表面活性剂占组合物中阴离子表面活性剂的92至100重量%,优选100重量%。
适用的牛磺酸盐表面活性剂可以包括牛磺酸的酰胺如N-甲基牛磺酸及其盐。适用的其它牛磺酸盐包括通常称为甲基月桂酰基牛磺酸钠、甲基月桂酰基牛磺酸钾、甲基肉豆蔻酰基牛磺酸钠、甲基肉豆蔻酰基牛磺酸钾、甲基肉豆蔻酰基牛磺酸铵、甲基椰油酰基牛磺酸钠、甲基椰油酰基牛磺酸钾、甲基椰油酰基牛磺酸铵、甲基油酰基牛磺酸钠、甲基油酰基牛磺酸钾、甲基油酰基牛磺酸铵、月桂酰基牛磺酸钠、月桂酰基牛磺酸钾、肉豆蔻酰基牛磺酸铵、椰油酰基牛磺酸钠、油酰基牛磺酸钾、它们的混合物等。
在优选的实施方式中,用于本发明的阴离子表面活性剂是甲基月桂酰基牛磺酸钠、甲基椰油酰基牛磺酸钠或其混合物。通常,阴离子表面活性剂占洗涤组合物的1至7重量%,优选1.5至6重量%,最优选2至5重量%,包括其中包含的所有范围。
适用的任选阴离子表面活性剂(即,当阴离子表面活性剂不是100%牛磺酸盐时)包括脂肪族磺酸盐,例如,伯烷烃(例如,C8-C22)磺酸盐、伯烷烃(例如,C8-C22)二磺酸盐、C8-C22烯烃磺酸盐、C8-C22羟基烷烃磺酸盐或烷基甘油醚磺酸盐(AGS);或芳族磺酸盐,如烷基苯磺酸盐。任选的阴离子表面活性剂也可以是烷基硫酸盐(例如,C12-C18烷基硫酸盐)或烷基醚硫酸盐(包括烷基甘油基醚硫酸盐)。使用的阴离子表面活性剂也可以包括烷基磺基琥珀酸盐(包括单烷基和二烷基,例如C6-C22磺基琥珀酸盐);烷基和酰基肌氨酸盐、磺基乙酸盐、C8-C22烷基磷酸盐和膦酸盐、烷基磷酸酯和烷氧基烷基磷酸酯、酰基乳酸盐、C8-C22单烷基琥珀酸盐和马来酸盐、磺基乙酸盐、烷基葡糖苷和酰基羟乙基磺酸盐、它们的混合物等。
可以与牛磺酸盐一起使用的羟乙基磺酸盐包括C8-C18酰基羟乙基磺酸盐(包括具有取代的头基的那些)。这些酯是通过碱金属羟乙基磺酸盐与具有6至18个碳原子且碘值小于20的混合脂族脂肪酸之间的反应制备的。通常至少75%的混合脂肪酸具有12至18个碳原子,最多25%的混合脂肪酸具有6至10个碳原子。
所用的酰基羟乙磺酸盐可以是烷氧基化的羟乙磺酸盐,如I于1995年2月28日授权的标题为“Fatty Acid Esters of Polyalkoxylated isethonic acid”的lardi等人的美国专利No.5,393,466中所述的;在此引入作为参考。支链羟乙基磺酸盐也适用。
在本发明的实施方式中,除牛磺酸盐之外使用的阴离子表面活性剂是月桂酰基甘氨酸钠、椰油酰基甘氨酸钠、月桂酰基谷氨酸钠、椰油酰基谷氨酸钠、月桂酰基羟乙基磺酸钠、椰油酰基羟乙基磺酸钠或其混合物。这种阴离子表面活性剂可从供应商如GalaxySurfactants、Clariant、Sino Lion和Innospec购得。椰油酰基羟乙基磺酸钠、甲基月桂酰基羟乙基磺酸钠或其混合物通常是适合与本发明洗涤组合物中存在的牛磺酸盐表面活性剂一起使用的优选阴离子表面活性剂。
两性和/或两性离子表面活性剂及非离子表面活性剂或阳离子聚合物或其混合物(分别地,“组分i和ii”)与阴离子表面活性剂(“组分iii”)的重量比为1:4至2:1,优选1:3至1.5:1,最优选1:2.5至1.35:1,包括其中包含的所有重量比。两性和/或两性离子表面活性剂(“组分i”)与非离子表面活性剂或阳离子聚合物或其混合物(“组分ii”)的重量比为1:12至12:1,优选1:8至8:1,最优选1:6至6:1,包括其中包含的所有重量比。
至于适用于本发明的多元醇,这些包括例如,山梨醇、甘油、甘露醇、木糖醇、麦芽糖醇或其混合物。在本发明的实施方式中,基于洗涤组合物中所用多元醇的总重量,所用多元醇是至少50重量%的甘油。在本发明的另一个实施方式中,所用的多元醇全部是甘油,基于洗涤组合物中多元醇的总重量的100重量%。多元醇通常占洗涤组合物的大于5至55重量%,优选占洗涤组合物的10至30重量%,最优选占洗涤组合物的10至25重量%,包括其中包含的所有范围。
水通常占组合物的50至96重量%,优选60至94重量%,优选65至92重量%,包括其中包含的所有范围。
可以使用适于调节/缓冲pH值的调节剂。这种pH调节剂包括三乙胺、NaOH、KOH、H2SO4、HCl、C6H8O7(即柠檬酸)或其混合物。以产生所需最终pH的量加入pH调节剂。可以用商业仪器评估pH值,例如,可从Thermo商购获得的pH计。
适用于本发明洗涤组合物的任选皮肤有益剂仅限于它们能够局部施用,并适合在所需pH下溶解在洗涤组合物中的程度。
适合包含在洗涤组合物的水部分中的有益剂的说明性实例是酸,如氨基酸,如精氨酸、缬氨酸或组氨酸。适用的其它水溶性有益剂包括维生素B2、烟酰胺(维生素B3)、维生素B6、维生素C、它们的混合物等。也可以使用这些维生素的水溶性衍生物。例如,维生素C衍生物如抗坏血酸四异棕榈酸酯、抗坏血酸磷酸镁和抗坏血酸糖苷,可以单独使用或相互结合使用。适用的其它水溶性有益剂包括4-乙基间苯二酚、提取物(如鼠尾草、芦荟、绿茶、葡萄籽、百里香、洋甘菊、蓍草、黄瓜、甘草、迷迭香提取物)、4-乙基间苯二酚或其混合物。也可以使用水溶性防晒剂,如恩素利唑。当存在于本发明中时,基于洗涤组合物的总重量,任选的水溶性有益剂(包括混合物)的总量可以为洗涤组合物的0.0至10重量%,优选0.001至8重量%,最优选0.01至6重量%的范围,并且包括其中包含的所有范围。
任选地包括油溶性(即非水溶性)有益剂也在本发明的范围内。洗涤组合物基本上不含油(即0.0至5重量%,优选0.01至3.5重量%,最优选0.1至2.5重量%的油),并且优选地,油不意味着包括从香料添加的任何油。因此,油溶性活性物质或有益试剂通常溶解在洗涤组合物中使用的表面活性剂中。对于这种油溶性有益剂的唯一限制是当局部施用时,该有益剂适于提供有益效果。
可任选地用于本发明组合物的油溶性有益剂的类型的说明性实例包括如硬脂酸、维生素(如维生素A、D、E和K,及其油溶性衍生物)、防晒剂(如乙基己基甲氧基肉桂酸酯、双乙基己基氧基酚甲氧基酚三嗪、2-乙基己基-2-氰基-3,3-二苯基-2-丙酸、甲酚曲唑三硅氧烷、3,3,5-三甲基环己基2-羟基苯甲酸酯、2-乙基己基-2-羟基苯甲酸酯)或其混合物的组分。
适用的其它任选的油溶性有益剂包括间苯二酚类,如4-己基间苯二酚、4-苯乙基间苯二酚、4-环戊基间苯二酚、4-环己基间苯二酚、4-异丙基间苯二酚或其混合物。也可以使用5-取代的间苯二酚类,如4-环己基-5-甲基苯-1,3-二醇、4-异丙基-5-甲基苯-1,3-二醇、它们的混合物等。在共同转让的美国专利申请公开No.2016/0000669A1中描述了5-取代的间苯二酚类及其合成。
甚至其它适用的油溶性活性物质包括ω-3脂肪酸、ω-6脂肪酸、氯咪巴唑、法呢醇、熊果酸、肉豆蔻酸、香叶基香叶醇、油烯基甜菜碱、椰油酰基羟乙基咪唑啉、己酰基鞘氨醇、12-羟基硬脂酸、岩芹酸、共轭亚油酸、松油醇、百里酚及其混合物等。
在本发明的实施方式中,所用的任选油溶性有益剂是视黄酸前体。在本发明的一个实施方式中,视黄酸前体是视黄醇、视黄醛、丙酸视黄酯、棕榈酸视黄酯、乙酸视黄酯或其混合物。丙酸视黄酯、棕榈酸视黄酯及其混合物通常是优选的。
当任选的油溶性有益剂用于本发明的洗涤组合物中时,这种有益剂通常占洗涤组合物的0.0至0.75重量%,优选0.001至5重量%,最优选0.05至0.35重量%。在又一个实施方式中,油占洗涤组合物总重量的0.1至0.6重量%,包括其中包含的所有范围,并且不包括由香料提供的任何油。
常规的防腐剂可以合意地加入到洗涤组合物中,以防止潜在有害的微生物的生长。化妆品化学家熟悉合适的防腐剂,并经常选择它们来满足防腐剂挑战测试并提供产品稳定性。适用的传统防腐剂包括乙内酰脲衍生物和丙酸盐。特别优选的防腐剂是苯甲酸钠、碘丙炔基丁基氨基甲酸酯、苯氧基乙醇、羟基苯乙酮、乙基己基甘油、己二醇、对羟基苯甲酸甲酯、对羟基苯甲酸丙酯、咪唑烷基脲、脱氢乙酸钠、二甲基-二甲基(DMDM)乙内酰脲和苯甲醇及其混合物。其他适用的防腐剂包括脱氢醋酸钠、氯苯甘醚和癸二醇。防腐剂的选择应考虑到组合物的用途以及防腐剂和乳液中其它成分之间可能的不相容性。防腐剂优选以洗涤组合物总重量的0.01重量%至2.0重量%范围的量使用,包括其中包含的所有范围。同样优选的是单独羟基苯乙酮或与其他防腐剂混合的防腐剂体系,以及使用0.2至1.0重量%的1,2-辛二醇的防腐剂体系。
本发明的洗涤组合物中可以任选地包含香料、固定剂、螯合剂(如EDTA)、遮光剂(如二氧化钛)和润肤剂。这些物质中的每一种的范围可以为洗涤组合物总重量的约0.03至约4%重量,优选0.1至2重量%之间,包括其中包含的所有范围。就使用润肤剂而言,所选择的润肤剂应当具有足够小的粒度,使得它们不会妨碍用于分配本发明组合物的任何包装的性能。
可以任选地使用HLB大于8的常规乳化剂。说明性的实例包括吐温40、60、80、聚山梨醇酯20及其混合物。通常,用于水连续系统的乳化剂,当使用时,占洗涤组合物重量的0.03至1.5%。
至于本发明的洗涤组合物,其通常具有基于洗涤组合物的总重量的1至20重量%,优选地2至18重量%,最优选地3至12重量%的总表面活性剂,并且包括其中包含的所有范围。在本发明的实施方式中,洗涤组合物包含基于洗涤组合物的总重量的4.5至11重量%的总表面活性剂,并且包括其中包含的所有范围。
适用于本发明洗涤组合物的再其它的任选添加剂包括桉油、薰衣草油、N,N-二乙基间甲苯酰胺(DEET)、羟甲辛吡酮(吡罗克酮)、吡啶硫酮锌、苄索氯铵、苯扎氯铵、西曲氯铵、氯化苯二甲烃铵、氯二甲酚、三氯生、十六烷基氯化吡啶鎓、氧化银、硝酸银、硫酸银、磷酸银、碳酸银、乙酸银、苯甲酸银或其混合物。如果使用的话,这些添加剂通常和共同构成洗涤组合物的0.0001至5重量%,和0.001至4重量%,最优选0.01至2.5重量%,包括其中包含的所有范围。
典型地,洗涤组合物的粘度低于20,000cps。洗涤组合物的粘度通常为10至15,000cps,优选20至10,000cps,最优选20至8,000cps,包括其中包含的所有范围。在本发明的实施方式中,洗涤组合物的粘度为25至6,000cps,在本发明的另一个实施方式中,洗涤组合物的粘度为50至5,000cps。
当制备本发明的洗涤组合物时,可以用常规设备在中等剪切和大气条件下混合所需的成分,温度为30-85℃,由此继续剪切直到回收均匀的产品。
只要组合物可以被分配,洗涤组合物的包装通常不受限制。在本发明的实施方式中,洗涤组合物以小袋、瓶(包括喷雾瓶)、坛子、管、小毛巾(例如擦拭巾,优选可生物降解的擦拭巾)或罐的形式出售。包装优选地允许无限次的再填充,从而必然减少环境中的塑料废物。在通常期望的实施方式中,包装是可生物降解的和/或由至少50重量%,优选至少75重量%的消费后树脂制成。
实施例提供用于便于理解本发明。它们不旨在限制权利要求的范围。
实施例I
在大气压力和大约50℃的温度的条件下,通过用适度剪切混合表中所列的成分来制备组合物。继续混合直到获得均匀的组合物。如下所述,对所有组合物评估眼睛刺激(即发红)。眼球、眼睑和流泪的评估由医生,眼科专家进行。小组成员的评估是基于小组成员在指定时间的组合物接触后的自我感知和视觉检查。发红是指眼球结膜和眼睑结膜的发红。
将产品(5%溶液)滴注到小组成员的眼部区域,并按照Khanna等,Human OcularResponse to Instillation of Surfactant Solutions and Water Across 10,000Subjects,Altex Proceedings,1/12,Proceedings of WC8(2012)中所述的实施评估方案。
组合物A
所用的并被确定为组合物A的制剂是市售的婴儿洗发水,其含有水、椰油酰胺丙基甜菜碱、椰油葡糖苷、甲基2-磺基月桂酸钠/2-磺基月桂酸二钠、柠檬酸、十六烷基甜菜碱、甘油、聚季铵盐-7、苯甲酸钠和香料。使用这种产品是因为它被宣传为无刺激和不流泪的婴儿洗涤组合物。
组合物B
*与本发明不一致的传统组合物。
**UCARE Polymer JR-30M
组合物C
*阳离子聚合物占非离子表面活性剂总重量的7.5%,存在非离子表面活性剂。
**UCARE Polymer JR-400;***
组合物D
*阳离子聚合物占表面活性剂总重量的8%,不存在非离子表面活性剂。
**UCARE Polymer JR-30M
通过(passing)标准
通过被定义为在立即使用/接触时或以15分钟间隔评估后没有3的得分,并且在60分钟时间点所有终点得分为0(即,在小组成员使用后没有不合格),并且在小组成员的所有评估后,在15分钟时间点100%的流泪得分为0(无)和/或1(轻度)。
0-通过-无视觉刺激、不适、发红和/或眼睛水样、流泪或溢泪。
1-通过-非常轻微至可忽略的刺激、不适、可视发红和/或眼睛水样、流泪或溢泪。
2-通过-刺激、可视发红(眼球和眼睑)。
3-不合格,严重视觉刺激,和/或严重不适和/或严重程度的眼睛水样、流泪或溢泪。
实施例II
处理的右侧的数字(即,产品、未使用产品的眼睛中的对照水)描述了对对照产品(组合物A)给出该得分的小组成员(总共25人)的人数。小组成员的其余部分意味着给出或评估为具有高通过零分数(0)的小组成员的人数。
/>
实施例III
组合物B的评估被终止。该组合物不是根据本发明制备的,且在开始由四(4)名小组成员进行评估后,三名小组成员立即得出评估研究不合格。
对于组合物C和D,处理(即产品、水)的右边的数字描述了对这些产品给出该得分的小组成员(总共15人)的人数。小组成员的其余部分意味着给出或评估为具有高通过零分数(0)的小组成员的人数。
实施例IV
/>
实施例V
/>
如对于与本发明一致的具有表面活性剂和阳离子聚合物的本发明组合物所观察到的,令人惊讶地获得了无刺激性的组合物。此外,用本发明的组合物洗涤的经过训练的小组成员得出结论,该组合物具有优异的起泡特性。
Claims (16)
1.一种组合物,其包含:
a)包含以下的表面活性剂组分:
i)两性和/或两性离子表面活性剂;
ii)非离子表面活性剂、阳离子聚合物或其混合物;和
iii)阴离子表面活性剂,该阴离子表面活性剂包含基于阴离子表面活性剂总重量的25至100重量%的牛磺酸盐;
iv)从大于5至55重量%的多元醇;和
v)水,
其中所述两性和/或两性离子表面活性剂及非离子表面活性剂或阳离子聚合物或其混合物(分别为“组分i和ii”)与阴离子表面活性剂(“组分iii”)的重量比为1:4至2:1,且所述两性和/或两性离子表面活性剂(“组分i”)与非离子表面活性剂或阳离子聚合物或其混合物(“组分ii”)的重量比为1:12至12:1,条件是当阳离子聚合物单独使用或与非离子表面活性剂一起使用时,使用的阳离子聚合物总重量相对于洗涤组合物中表面活性剂的总重量为表面活性剂总重量的1.3重量%至不超过15重量%,并且所述洗涤组合物包含20重量%或更少的总表面活性剂和阳离子聚合物,并且进一步地其中所述两性表面活性剂包含甜菜碱,所述阳离子聚合物包含羟丙基三甲基氯化铵和/或羟乙基纤维素,和所述非离子表面活性剂包含葡糖酰胺。
2.根据权利要求1所述的组合物,其中所述两性表面活性剂存在,并且是酰基两性乙酸钠、酰基两性丙酸钠或其混合物。
3.根据权利要求1所述的组合物,其中所述两性表面活性剂存在,并且是月桂酰两性乙酸钠、椰油酰两性乙酸钠、月桂酰两性乙酸钾、椰油酰两性乙酸钾或其混合物。
4.根据权利要求1所述的组合物,其中所述两性表面活性剂存在,并且是月桂酰两性乙酸钠。
5.根据前述权利要求中任一项所述的组合物,其中两性表面活性剂占组合物重量的0.5至7%,优选1至6%,最优选1至5%。
6.根据前述权利要求中任一项所述的组合物,其中两性离子表面活性剂存在,并且是月桂基甜菜碱、柠檬酸甜菜碱、椰油二甲基羧甲基甜菜碱、椰油酰胺丙基甜菜碱、椰油烷基二甲基甜菜碱和月桂基酰胺丙基甜菜碱或其混合物。
7.根据前述权利要求中任一项所述的组合物,其中两性离子表面活性剂存在,并且为椰油酰胺丙基甜菜碱、椰油酰胺丙基磺基甜菜碱、椰油酰胺丙基羟基磺基甜菜碱、羟甲基甘氨酸钠、(羧甲基)二甲基-3-[(1-氧代十二烷基)氨基]丙基氢氧化铵、(羧甲基)二甲基油烯基氢氧化铵、椰油酰胺丙基甜菜碱、(羧甲基)二甲基油烯基氢氧化铵、椰油酰胺丙基甜菜碱、(羧甲基)二甲基(十八烷基)铵、椰油酰胺丙基羟基磺基甜菜碱、椰油烷基二甲基甜菜碱、椰油二甲基羧甲基甜菜碱、椰油酰胺丙基甜菜碱、月桂基酰胺丙基甜菜碱或其混合物。
8.根据前述权利要求中任一项所述的组合物,其中两性离子表面活性剂存在,并且是椰油酰胺丙基甜菜碱、椰油酰胺丙基羟基磺基甜菜碱或其混合物。
9.根据前述权利要求中任一项所述的组合物,其中两性离子表面活性剂占组合物重量的0.5至7%,优选1至6%,最优选1至5%。
10.根据前述权利要求中任一项所述的组合物,其中所述两性离子表面活性剂存在,并且为月桂基甜菜碱、柠檬酸甜菜碱、椰油二甲基羧甲基甜菜碱、月桂基酰胺丙基甜菜碱、椰油酰胺丙基甜菜碱、椰油酰胺丙基磺基甜菜碱、椰油酰胺丙基羟基磺基甜菜碱、月桂基甜菜碱、柠檬酸甜菜碱、羟甲基甘氨酸钠、(羧甲基)二甲基-3-[(1-氧代十二烷基)氨基]丙基氢氧化铵、椰油烷基二甲基甜菜碱、(羧甲基)二甲基油烯基氢氧化铵、(羧甲基)二甲基油烯基氢氧化铵、椰油酰胺丙基甜菜碱、(羧甲基)二甲基(十八烷基)铵、椰油酰胺丙基羟基磺基甜菜碱或其混合物。
11.根据前述权利要求中任一项所述的组合物,其中两性离子表面活性剂占组合物重量的0.5至7%,优选1至6%,最优选1至5%。
12.根据权利要求1所述的组合物,其中所述组合物包含月桂酰两性乙酸钠、椰油酰胺丙基甜菜碱、椰油酰胺丙基羟基磺基甜菜碱或其混合物,以及葡糖酰胺、聚甘油酯或两者。
13.根据前述权利要求中任一项所述的组合物,其中所述多元醇是甘油,并且以所述组合物的10至30重量%存在。
14.根据前述权利要求中任一项所述的组合物,其中所述阳离子聚合物或非离子表面活性剂存在,并且所述组合物是婴儿用洗涤组合物、2合1组合物或3合1组合物。
15.根据权利要求1-11中任一项所述的组合物,其中所述非离子表面活性剂是月桂酰基甲基葡糖酰胺、肉豆蔻酰基甲基葡糖酰胺、椰油酰基甲基葡糖酰胺、辛酰基/己酰基甲基葡糖酰胺、向日葵酰基甲基葡糖酰胺、聚甘油-8辛酸酯、聚甘油-8癸酸酯、聚甘油-8月桂酸酯、聚甘油-8肉豆蔻酸酯、聚甘油-8棕榈酸酯、聚甘油-8硬脂酸酯、聚甘油-8油酸酯、聚甘油-8椰油酸酯、聚甘油-9辛酸酯、聚甘油-9癸酸酯、聚甘油-9月桂酸酯、聚甘油-9肉豆蔻酸酯、聚甘油-9棕榈酸酯、聚甘油-9硬脂酸酯、聚甘油-9油酸酯、聚甘油-9椰油酸酯、聚甘油-10辛酸酯、聚甘油-10癸酸酯、聚甘油-10月桂酸酯、聚甘油-10肉豆蔻酸酯、聚甘油-10棕榈酸酯、聚甘油-10硬脂酸酯、聚甘油-10油酸酯、聚甘油-10椰油酸酯、聚甘油-11辛酸酯、聚甘油-11癸酸酯、聚甘油-11月桂酸酯、聚甘油-11肉豆蔻酸酯、聚甘油-11棕榈酸酯、聚甘油-11硬脂酸酯、聚甘油-11油酸酯、聚甘油-11椰油酸酯、聚甘油-12辛酸酯、聚甘油-12癸酸酯、聚甘油-12月桂酸酯、聚甘油-12肉豆蔻酸酯、聚甘油-12棕榈酸酯、聚甘油-12硬脂酸酯、聚甘油-12油酸酯、聚甘油-12椰油酸酯或其混合物。
16.根据权利要求1所述的组合物,其中所述两性表面活性剂是甜菜碱并且是椰油酰胺丙基甜菜碱,所述非离子表面活性剂是辛酰基/癸酰基甲基葡糖酰胺,和所述阳离子聚合物是羟丙基三甲基氯化铵和/或羟乙基纤维素,并且所述组合物包含黄原胶。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP20207496.9 | 2020-11-13 | ||
EP20207496 | 2020-11-13 | ||
PCT/EP2021/080746 WO2022101097A1 (en) | 2020-11-13 | 2021-11-05 | Wash composition |
Publications (1)
Publication Number | Publication Date |
---|---|
CN116648232A true CN116648232A (zh) | 2023-08-25 |
Family
ID=73448906
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202180076391.3A Pending CN116648232A (zh) | 2020-11-13 | 2021-11-05 | 洗涤组合物 |
Country Status (5)
Country | Link |
---|---|
US (1) | US20230414468A1 (zh) |
EP (1) | EP4243764A1 (zh) |
CN (1) | CN116648232A (zh) |
CA (1) | CA3195392A1 (zh) |
WO (1) | WO2022101097A1 (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2024002646A1 (en) * | 2022-06-30 | 2024-01-04 | Unilever Ip Holdings B.V. | Stable wash composition with biodegradable thickener |
CN115300405B (zh) * | 2022-08-11 | 2024-06-14 | 清远天赐高新材料有限公司 | 一种具有护色效果的发用组合物及其制备方法和应用 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3472840A (en) | 1965-09-14 | 1969-10-14 | Union Carbide Corp | Quaternary nitrogen-containing cellulose ethers |
CA1018893A (en) | 1972-12-11 | 1977-10-11 | Roger C. Birkofer | Mild thickened shampoo compositions with conditioning properties |
DE2750731C3 (de) | 1977-11-12 | 1983-05-11 | Rewo Chemische Werke Gmbh, 6497 Steinau | Betaine und diese Verbindungen enthaltende Reinigungs-,Bade- und Desinfektionsmittel |
US4663159A (en) | 1985-02-01 | 1987-05-05 | Union Carbide Corporation | Hydrophobe substituted, water-soluble cationic polysaccharides |
DE69214402T2 (de) | 1991-11-25 | 1997-03-20 | Unilever Nv | Fettsäureester von alkoxylierter Isethionsäure und sie enthaltende Reinigungsmittelzusammensetzungen |
US5407919A (en) | 1993-09-29 | 1995-04-18 | Brode; George L. | Double-substituted cationic cellulose ethers |
JP4040775B2 (ja) | 1998-12-11 | 2008-01-30 | ジョンソン・エンド・ジョンソン株式会社 | 洗浄剤組成物 |
US6372934B1 (en) | 2000-01-18 | 2002-04-16 | Biosil Research Institute | Water soluble complexes |
JP5006034B2 (ja) | 2003-06-17 | 2012-08-22 | ユニオン カーバイド ケミカルズ アンド プラスティックス テクノロジー エルエルシー | セルロースエーテル |
CN105142603B (zh) | 2013-03-08 | 2018-10-19 | 荷兰联合利华有限公司 | 用于皮肤病用途的间苯二酚化合物 |
TW201620491A (zh) * | 2014-10-31 | 2016-06-16 | 資生堂股份有限公司 | 毛髮用洗淨料 |
KR20180108834A (ko) * | 2016-02-16 | 2018-10-04 | 로디아 오퍼레이션스 | 개인 위생 조성물 및 이러한 조성물의 사용 방법 |
CN110582266A (zh) * | 2017-05-04 | 2019-12-17 | 强生消费者公司 | 改善的清洁组合物 |
-
2021
- 2021-11-05 WO PCT/EP2021/080746 patent/WO2022101097A1/en active Application Filing
- 2021-11-05 US US18/036,268 patent/US20230414468A1/en active Pending
- 2021-11-05 EP EP21801144.3A patent/EP4243764A1/en active Pending
- 2021-11-05 CA CA3195392A patent/CA3195392A1/en active Pending
- 2021-11-05 CN CN202180076391.3A patent/CN116648232A/zh active Pending
Also Published As
Publication number | Publication date |
---|---|
US20230414468A1 (en) | 2023-12-28 |
EP4243764A1 (en) | 2023-09-20 |
CA3195392A1 (en) | 2022-05-19 |
WO2022101097A1 (en) | 2022-05-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN116648232A (zh) | 洗涤组合物 | |
EP2925282B1 (en) | Mild antibacterial cleansing compositions | |
EP4110274B1 (en) | High polyol wash composition | |
WO2021245159A1 (en) | Naturally derived surfactant system and composition comprising the same | |
US20210220243A1 (en) | Hydratable Concentrated Surfactant Composition | |
US11857508B2 (en) | Isotropic concentrate and wash compositions | |
US20230049117A1 (en) | Hydratable concentrated surfactant composition | |
US11382847B2 (en) | High polyol wash composition | |
JPH07330553A (ja) | 毛髪化粧料 | |
US20230398050A1 (en) | Stable wash composition | |
JPH07138593A (ja) | 洗浄剤組成物 | |
WO2021245160A1 (en) | Naturally derived surfactant system with polyglycerol esters and compositions comprising the same | |
WO2023126229A1 (en) | Liquid composition having enhanced antimicrobial activity | |
WO2024002645A1 (en) | Reduced palm kernel reliant wash composition | |
WO2024002892A1 (en) | Anti-acne composition | |
CN117597100A (zh) | 包含具有限定重量百分比的氧的化合物的可水合浓缩表面活性剂组合物 | |
JP2003300842A (ja) | 化粧料 | |
US20240189202A1 (en) | Hydratable concentrated surfactant composition substantially free of isethionates | |
WO2024002646A1 (en) | Stable wash composition with biodegradable thickener | |
JP2019056127A (ja) | アスパラギン酸のタウリン誘導体を含有する界面活性剤組成物及び当該界面活性剤組成物を含有する洗浄剤組成物 | |
AU2011278492A1 (en) | Foam enhancement of fatty acyl glycinate surfactants |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |